西洋参茎叶皂苷对局灶性脑缺血大鼠脑组织NGF和TGF-β_1含量的影响
|
摘要
目的:研究西洋参茎叶皂苷(PQS)对大鼠局灶性脑缺血损伤的神经保护作用及作用机制。
方法:
采用雄性Wistar大鼠,PQS 50、100㎎·㎏-1灌胃给药,连续7d后利用线栓法建立大鼠大脑中动脉栓塞模型,造模后0h、24h按Longa法进行2次神经功能评分,光镜观察脑组织病理形态改变;并采用酶联免疫吸附法(ELISA法)检测造模24h后患侧脑组织中NGF及TGF-β1的含量。
结果:
1.PQS能明显改善局灶性脑缺血大鼠神经功能缺损体征,降低神经功能缺损评分,减轻缺血脑组织病理形态学改变。
2. PQS能明显提高局灶性脑缺血大鼠脑组织NGF的含量。
3. PQS能明显提高局灶性脑缺血大鼠脑组织TGF-β1的含量。
结论:PQS对局灶性脑缺血损伤具有保护作用,其作用机制可能与诱导缺血脑组织中NGF、TGF-β1的表达有关。
Objective: To investigate the protective effects of Panax quinquefolium saponins from steams and leaves (PQS) on focal cerebral ischemia damage and its mechamism.
Method:
The male rats were pretreated with PQS 50 and 100㎎·㎏ -1 ig, one time per day for 7d, and then subjected to focal cerebral ischemia damage induced by a middle cerebral artery occlusion(MCAO) for 24h. Determined neurological symptom by Longa’s score at the point 0h,24h after cerebral ischemia, and then drawn, brain tissue pathological changes was observed by light microscope; and using enzyme-linked immunosorbent assay (ELISA) test to detect the contents of NGF and TGF-β1 seperately in ipsilateral brain tissue.
Results:
1.PQS can significantly improve the focal cerebral ischemia in rats signs of neurological deficit, reduced neurological deficit scores, reduce the pathological changes of ischemic brain tissue.
2.PQS can significantly increased the content of NGF in rat brain after focal cerebral ischemia.
3.PQS can significantly increased the content of TGF-β1 in rat brain after focal cerebral ischemia.
Conclusions: PQS has protective effects on focal cerebral ischemia damage and its mechanism may be related to inducing the expression of NGF and TGF-β1.
方法:
采用雄性Wistar大鼠,PQS 50、100㎎·㎏-1灌胃给药,连续7d后利用线栓法建立大鼠大脑中动脉栓塞模型,造模后0h、24h按Longa法进行2次神经功能评分,光镜观察脑组织病理形态改变;并采用酶联免疫吸附法(ELISA法)检测造模24h后患侧脑组织中NGF及TGF-β1的含量。
结果:
1.PQS能明显改善局灶性脑缺血大鼠神经功能缺损体征,降低神经功能缺损评分,减轻缺血脑组织病理形态学改变。
2. PQS能明显提高局灶性脑缺血大鼠脑组织NGF的含量。
3. PQS能明显提高局灶性脑缺血大鼠脑组织TGF-β1的含量。
结论:PQS对局灶性脑缺血损伤具有保护作用,其作用机制可能与诱导缺血脑组织中NGF、TGF-β1的表达有关。
Objective: To investigate the protective effects of Panax quinquefolium saponins from steams and leaves (PQS) on focal cerebral ischemia damage and its mechamism.
Method:
The male rats were pretreated with PQS 50 and 100㎎·㎏ -1 ig, one time per day for 7d, and then subjected to focal cerebral ischemia damage induced by a middle cerebral artery occlusion(MCAO) for 24h. Determined neurological symptom by Longa’s score at the point 0h,24h after cerebral ischemia, and then drawn, brain tissue pathological changes was observed by light microscope; and using enzyme-linked immunosorbent assay (ELISA) test to detect the contents of NGF and TGF-β1 seperately in ipsilateral brain tissue.
Results:
1.PQS can significantly improve the focal cerebral ischemia in rats signs of neurological deficit, reduced neurological deficit scores, reduce the pathological changes of ischemic brain tissue.
2.PQS can significantly increased the content of NGF in rat brain after focal cerebral ischemia.
3.PQS can significantly increased the content of TGF-β1 in rat brain after focal cerebral ischemia.
Conclusions: PQS has protective effects on focal cerebral ischemia damage and its mechanism may be related to inducing the expression of NGF and TGF-β1.
引文
[1]方向华.中国卒中的流行现状及其影响因素.中国脑血管病杂志,2004,l(5): 233-237.
[2]倪青,于丽红,高演.急性缺血性中风中医药研究[J].中西医结合心脑血管病杂志, 2008,6(2):127-128.
[3]于晓东.《内经》对中风病因的认识[J].时珍国医国药,2008,19(1):213-214.
[4]窦志芳,郭蕾,张俊龙,张鑫.唐宋以前中风病证治规律研究[J].中西医结合心脑血管病杂志,2006,4(4):325-326.
[5]张仲景.金匮要略方论[M].北京:人民卫生出版社,1963:14.
[6]王永炎.中医内科学[M].上海:上海科学技术出版社,1997:124.
[7]滕晶.中风病病因病机理论探析[J].中华中医药学刊,2007,25 (5):962-963.
[8]田德禄.中医内科学[M].北京:人民卫生出版社,2004:270-271.
[9]李澎涛,王永炎,黄启福.“毒损脑络”病机假说的形成及其理论与实践意义[J].北京中医药大学学报,2001,24(1):1.
[10]高颖.中风病的病因病机与辨证论治[J].中国临床医生,2001,29 (3):9-11.
[11]粟秀初.现代脑血管病学[M].北京:人民军医出版社,2003:82.
[12]刘柯,李建生.益气化瘀法对缺血性脑卒中保护作用的实验研究进展[J].中国医药学报,2004,1(19):60-64.
[13]苏志达,李瑜,李宏建.卒中治疗药物临床前的实验研究[J].国外医学脑血管疾病分册,2000,8(5):290-293.
[14]徐俊,王立.脑缺血时一氧化氮在谷氨酸兴奋毒性中的作用[J].国外医学脑血管疾病分册,1998,6(5):259-263.
[15]Hirose K,Chan PH.Blockade of glutamate excitotoxicityand its clinical applications[J].Neurochem Res,1993,18:469-483.
[16]Kristian T,Siesj BJ.Calcium-related damage in ischemia[J].Life Sci,1996,59 (516):357.
[17]陈敏,李长清,胡长林,等.钙与脑缺血/再灌注后神经细胞凋亡[J].脑与神经疾病杂志,2003,11(4):253-255.
[18]王树礼,黄晓磊,庄姗姗,杜书静.钙超载、钙结合蛋白-D28k与脑缺血关系的研究进展[J].滨州医学院学报,2009,32(1):63-66.
[19]周爽,黄建华.电针对脑缺血再灌注损伤大鼠炎症反应的影响[J].江苏中医药2005,(26)7:49-51.
[20]刘宏,吴平生.全脑缺血再灌注后发生迟发性神经元死亡的机制[J].国外医学·生理、病理科学与临床分册,1999,19(5):379-382.
[21]Reiter RJ. Oxidative damage in the central nervous system:Protection by melatonin[J].ProgNeurobio,1998,56:359-384.
[22]吴伟,史继新.脑缺血再灌注损伤后神经元损伤机制及治疗研究进展[J].中国微循环.2003,7(6):391-394.
[23]刘煜敏,徐仁伵,黄怀钧等.兴奋性氨基酸、氧自由基与缺氧再灌注脑损伤关系的实验观察[J].卒中与神经疾病.2000,7(2):98-100.
[24]张玲,余绍祖,吴国祥.大鼠脑缺血再灌注TNF-α、IL-β及细胞间粘附分子-1 mRNA的表达[J].卒中与神经疾病.2001,8(2):77-79.
[25]Shigeno T,Yamask i Y, Kato G, et al. Reduction of delayed neuronal death by inhibition protein synthesis[J]. N euro scilett,1990,120:1171-1184.
[26]Huang J,Upadhyay UM,Tamargo RJ.Inflammation in stroke and focal cerebral ischemia [J].Surg Neurol,2006,66(3):232-245.
[27]Wang Q,Tang XN,Yenari MA. The inflammatory response in stroke[J]. Neuroimmunol,2007,184(1-2):53-68
[28]方舒东,朱也森.脑缺血再灌注损伤的病理生理研究进展[J].医学综述,2006,12(18):1114-1116.
[29]Du C,Hu R,Csernansky CA,et al.Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis[J]. J Cereb Blood Flow Metab,1996, 16(2): 195-201.
[30]Hill IE,MacManus JP,Rasquinha I,et al.DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Res,1995,676(2):398-403.
[31]Wolf CM, Eastman A.The temporal relationship between protein-phosphatase,mitochondrial cytochrome C release and Caspase activation in apoptosis[J].EXP cell Res,1999,247(2):501-503.
[32]Mc Conkey DJ, Orrenius ST.The role of calcium in the regulation of apoptosis[J].Leukoc Biol,1996,59(6):725.
[33]Dodel RC,Da Y,Bales KR,et al.Caspase-3-like proteases and 6-hydrocy -Dopamine induced neuronal cell death[J].Brain Res Mol Brain Res,1999, 64(l):141.
[34]Dietrich WD,et al.Effect of the serotonin antagonist Ketomserin on the Modynamic infarction[J].Cereb Blood Flow Metab,1989,9:812-820.
[35]徐涛,曲方,周中和,宋福林.阿司匹林对脑缺血-再灌注损伤大鼠神经保护作用的机制[J].中国脑血管病杂志,2006,3(6):267-272.
[36]谭言敏.阿司匹林预防缺血性脑卒中[J].国外医学--脑血管疾病分册,1995, 3(3):131.
[37]Hoener MC,Hewirr E,Connner HM,et al.Nerve growth factor(NGF)content in adult rat brain tissues is several-fold higher than generally reported and id largely associated with sedimentable fractions[J].Brain Res,1996,728(1): 47-56.
[38]Yuen EC,Mobley WC.Therapeutic potential of neurotrophic factors for neurological disorders[J]. Ann Neurol,1996,40(3):346-354.
[39]Holtzman DM,Sheldom RA,Jaffe W,et al.Nerve growth factor proctects the neonatal brain against ischemic injury[J].Ann Neurol,1996,39(1):114-122.
[40]Arevalo MA,Rodríguez-Tébar A.Activation of casein kinase II and inh-ibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTRNTR inhibit glycogen syn-thase kinase-3βand stimulate axonal growth[J].Mol Biol Cell,2006,17(8):3369-3377.
[41]Colquhoun A,Lawrance GM,Shamovsky IL,et al.Differential activity of the nerve growth factor (NGF) antagonist PD90780 suggests altered NGF-p75NTRNTR interactions in the presence of TrkA[J].J Pharma-col Exp Ther,2004,310(2):505-511.
[42]Takeda A,Onodera H,Sugimoto A,et al.Coordinated expression of messenger RNAs for nerve growth factor,brain-derived neurotrophic factor and neurotrophin– 3 in the rat hippocampus following transient forebrain ischemia [J].Neuroscience, 1993,55(1):23-31.
[43]Hsu CY,An G,Liu JS,et al.Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat[J].Stroke,1993,24(12): 178-181.
[44]Aloe L,Lannitelli A.Neurotrophic factors and brain damage in hypoxic-ischemic encephalopathy:a role of nerve growth factor[J].Ann Ist Super Sanita,2001,37(4): 573-580.
[45]Lindvall O,Kokaia Z,Bengzon J,et al. Neurotrophins and brain insults[J].Trend Neurosci,1994,17(11):490-496.
[46]Hohn A,Leibrock J,et al.Demonstration of the retrograde transport of nerve growth factor(NGF) receptor in the peripheral and central nervous system[J]. Nature,1991,344:339.
[47]Frin D M,Short M P,Rosenberg W S,et al.Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum [J].Neurosrug,1993,78(2):267-273.
[48]Cheng B,Mattson MP.NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults[J]. Brain Res,1994,640(1):56-67.
[49]Guegan C,Ceballos Picot I,Chebalier E,et al.Reduction of ischemic damage in NGF-transgenic mice:correlation with enhancement of antiosidant enzyme activeties [J].Neurobiol Dis,1999,6(3):180-189.
[50]Cheng B,McMahon D,Mattson MP.Modulation of calcium current,intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons[J].Res,1993,607(1-2):275-285.
[51]Zhai S,Yssr M,Doyle S M,et al.Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating bcl-2 levels[J].Exp Cell Res,1996, 224(2):335-343.
[52]毕方方.NGF对大鼠局灶性脑缺血后血管再生的作用及其机制[D]湖南:中南大学,2007: 3-25.
[53]LukYO,Chen WY,Wang WJ,et al.Treatment of focal cerebral ischemia with liposomal nerve growth factor[J].DrugDeliv,2004,11(5):319-324.
[54]Ding Y,LI J,Luan X,et al.Exercise pre-conditioning reduces brain damage inischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin[J].Neuroscience,2004,124(3):583-591.
[55]Andsberg G,Kokaia Z,Klein RL,et al.Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats[J].NeurobiolDis, 2002,9(2):187-204.
[56]Andsberg G,Kokaia Z,Bjorklund A,et al.Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells[J].Eur J Neurosci,1998,10(6):2026-2036.
[57]Massagué,J.TGF signal transduction[J].Annu.Rev.Biochem,1998,67:753-791.
[58]Brand,Thomas,Schneider,et al.Transforming Growth Factor-beta signal transduction[J].American Heart Association,1996,76(2):173-179.
[59]Massagué,J.The transforming growth factor-beta family[J].Annu Rev Ce11 Biol,1990,6:597-641.
[60]Sporn MB,Roberts AB,Roche NS,et al.Transforming growth factor-beta; biological function and chemical structure[J].Science,1986,233(4763):532-534.
[61]Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose6-phosphate insulin -like growth factor typeⅡreceptor[J].Proc Nat l Acad Sci USA,1991,88(2): 580-584.
[62]刘士民,郭玉璞.大鼠局灶脑缺血/再灌注模型TGF-βl的表达[J].基础医学与临床,2000,20(l):70-73.
[63]Massague J. Receptors for the TGF-beta family[J].Cell,1992,69(7):1067.
[64]Ebner R,Chen RH,Shum L,et al.Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the typeⅡreceptor[J].Science,1993,260(5112): 1344.5
[65]Lehrmann E,Kiefer R,Finsen B,et al.Cytokines in cerebral ischemia: expression of transforming growth factor beta l(TGF beta l)mRNA in the post ischemic adult rat hippocampus[J].Esp Neurol,1995,131(l):114-123.
[66]Wang X,Yue TL,White RF,et al.Transforming growth factor beta 1 exhibitsdelayed gene expression following focal cerebral ischemia[J].Brain Res Bull,1995,36(6):607-609.
[67]Knuckey NW,Finch P,Palm DE,et al.Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia[J].Brain Res Mol Brain Res,1996,40(l): l-14.
[68]艾婷,孙晓勉.转化生长因子β1与缺氧缺血性脑损伤关系的研究进展[J].新生儿科杂志,2005,20(3):140-143.
[69]Henrich-Noack P,Prehn JH,Krieglstein J.TGF-beta l protects hippocampal neurons against degeneration caused by transient global ischemia. Dose response relationship and potential neuroprotective mechanisms[J].Stroke,1996, 27(9):1609-1614.
[70]Sometani A,Kataoka H,Nitta A,et al.Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor,TrkB,in neurons cultured from rat ccrebral cortex[J].J Neurosci Res,2001,66(3):369-376.
[71]DhandaPani KM,Brann DW.Transforming growth factor-beta:a neuroprotective factor in cerebral ischemia[J].Cell Biochem Biophys,2003,39(l):13-22.
[72]胡治平.转化生长因子β与缺血性脑损伤(综述)[J].国外医学神经病学神经外科学分册,2000,27(2):9799.
[73]Klaus Unsieker,Jens Strelau.Functions of transforming growth factor-βisoforms in the nervous system Cues based on localization and experimental in vitro and in vivoevidence[J].EJ.Bioehem,2000,267:6972-6975.
[74]Shih S,Ju M,Liu N,et al.Transforming growth factor induction of vascular endothelial growth factor receptor l:Mechanism of pericyte-inducted vascular survival in vivo[J]. Proc Natl Acad Sci USA,2003,100(26):15859-15864.
[75]John GR,Lee SC,Brosnan CF,et al.Cytokines: powerful regulators of glial cell activation[J].Neuroscientist,2003,9(1):10-22.
[76]KruPinski J,Kumar P,Kumar S,et al.Increased expression of TGF-beta 1 in brain tissue after ischemic storke in humans[J].Stroke,1996,27(5):852-857.
[77]Unsicker K,Krieglstein K.TGF-betas and their roles in the regulation ofneuronsurvival[J].Adv Exp Med Biol,2002,513:353-374.
[78]Brionne TC,Tesseur I,Masliah E,et al.Loss of TGF-βl leads to increased neuronal cell death and microgliosis in mouse brain[J].Neuron,2003,40: 1133-1145.
[79]Roussel S,Mackenzie ET,Vivien D,et al.A transforming growth factor beta antagonist unrnasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury[J].J Cereb Blood Flow Metab,1999,19(12): 1345-1353.
[80]刘铁成.中国西洋参[M].北京:人民卫生出版社,1995
[81]曹立军,许永华,于淑莲,等.我国西洋参产业发展现状概述[J].人参研究,2002, 14(1):36-38.
[82]都晓伟,刘艳艳,李滨.从化学和药理学的角度探讨人参、西洋参和三七的传统应用[J].中医药学报,2005,33(4):66-69.
[83]鲍建材,刘刚,郑友兰.西洋参中皂苷类成份的研究[J].人参研究,2004,(1):7-9.
[84]魏春雁,牟金明.西洋参化学成分研究现状[J].特产研究.1997,(4):39-41.
[85]王蕾,王英平,许世良,等.西洋参化学成份及药理活性研究进展[J].特产研究,2007,(3):73-77.
[86]任贵兴,王铁生,吕明山.西洋参根茎叶总皂苷、氨基酸及无机元素含量的研究[J].特产科学实验,1987,(4):1-3.
[87]陆丰,睢大员,于晓风,等.西洋参叶20S-原人参二醇组皂苷对急性心肌梗死大鼠交感神经递质及肾素-血管紧张素系统的影响[J].中草药,2001,32(7):619-621.
[88]武淑芳,睢大员,于晓风,等.西洋参20S-原人参二醇组皂苷抗实验性心肌缺血作用及其机制[J].中国药学杂志,2002,37(2):100-103.
[89]刘尚裕,睢大员,于小风,等.西洋参叶20S-原人参二醇组皂苷对急性心肌梗死犬血流动力学和氧代谢的影响[J].中国药学杂志,2001,36(1):25-29.
[90]睢大员,于晓风,曲绍春,等.西洋参叶20S-原人参二醇组皂苷对犬急性心肌梗死的保护作用[J].中国中药杂志,2001,26(6):416-419.
[91]边城,吕忠智.西洋参茎叶皂苷对实验性心肌坏死的保护作用[J].中国药理学通报,1994,10(6):442-444.
[92]王承龙,史大卓,殷惠军,陈可冀.西洋参茎叶总皂苷对急性心肌梗死大鼠心肌VEGF、bFGF表达及血管新生的影响[J].中国中西医结合杂志,2007,27( 4):331- 334.
[93]王尚农,马欣,赵东科.西洋参茎叶皂苷对豚鼠心室乳头状肌动作电位和收缩力的影响[J].西安医科大学学报,1994,15(2):122-124.
[94]杨世杰,李红,张文杰,等.西洋参茎叶皂苷对培养犬鼠心肌细胞钙通道阻断作用的初步观察[J].中国药学杂志,1994,29 (9):525-527.
[95]马欣,赵松珍,王尚农.西洋参茎叶皂苷对家兔窦房结电活动和豚鼠心肌收缩性的影响[J].西安医科大学学报,1998,19(1):47-48.
[96]关利新,衣欣,杨世杰,等.西洋参茎叶皂苷对大鼠心肌细胞Ca2+内流的影响[J].中药药理与临床,2004,20(6):8-9.
[97]杨世杰,陈立,赵华,等.西洋参茎叶皂苷对豚鼠左心房收缩力及右心房起搏点的作用[J].白求恩医科大学学报,1994,20(2):122-124.
[98]李智,于晓风,曲绍春,徐华丽,睢大员.西洋参叶20S-原人参三醇组皂苷对大鼠心肌缺血再灌注损伤的保护作用[J].2009,35(1):51-54.
[99]马琼英,周文祥,高鸣,等.西洋参茎叶皂苷对中分子物质损伤心肌的保护作用的实验研究[J].中国中西医结合肾病杂志,2000,1 (2):79-81.
[100]王承龙,缪宇,殷惠军,等.西洋参茎叶总皂苷对急性心肌梗死大鼠心肌能量代谢的影响[J].中华老年心脑血管病杂志,2005,7 (5):341-343.
[101]范宝晶,裴非,赵学忠.西洋参茎叶总皂苷对心肌肥厚大鼠血管内皮功能的影响[J].中国老年学杂志,2009,29(7):811-812.
[102]吕忠智,张清兰,于晓凤,周鸣.西洋参茎叶皂甙对实验性心肌梗塞的保护作用.白求恩医科大学学报,1990,16:229-23l.
[103]李松云,郭力达,王健春,章建邦.西洋参茎叶皂甙对失血性休克及对心脏的保护作用.中华医学杂志,1990,70:411-412.
[104]郭力达,李松云,王健春.西洋参茎叶总皂甙对失血性休克鼠组织过氧化脂质含量的影响.白求忍医科大学学报,1990,16:556-558.
[105]马春力,吕忠智,姜永冲.西洋参茎叶皂甙在阿霉素诱导大鼠心肌损伤中的抗氧化作用.中国药理学与毒理学杂志,1993,7:267-269.
[106]杨世杰,曲极冰,钟国,张文杰.西洋参茎叶皂甙对大鼠培养心肌细胞氧化损伤的保护作用.中国中药杂志,1992,17:555-557.
[107]李吉平,吕忠智,吕怡芳.西洋参茎叶皂甙对高脂血症大鼠脂蛋白-胆固醇代谢的影响及其抗氧化作用.中国药学杂志,1993,28:355-357.
[108]马春力,崔凤起,郭忠兴,王力.西洋参茎叶皂甙对老年大鼠血清和组织中超氧化物歧化酶的作用.老年学杂志,1993,13:304-305.
[109]马春力,李福全,赵玉珍.西洋参茎叶皂甙对急性乙醇中毒大鼠肝损害的影响.佳末斯医学院学报,1992,(6):18-19.
[110]刘巍.西洋参茎叶20s-原人参二醇组皂苷对大鼠实验性脑缺血的影响[D].长春:吉林大学药学院,2007:5-35.
[111]关利新,翟凤国,聂影,包海花,苏云明.西洋参茎叶皂苷对脑缺血大鼠细胞凋亡及caspase-3表达的影响[J].中药药理与临床,2008,24(1):30-32.
[112]包海花,袁晓环,韩雪山,高晓红,关利新,初彦辉.西洋参皂苷对H2O2致PC12细胞损伤的保护作用[J].中国生化药物杂志,2009,30(5):302-305.
[113]吕忠智,睢大篑.西洋参茎叶皂甙的心血管药理研究进展[J].中国药理学通报, 1996,12(5):395-396.
[114]殷惠军,张颖,蒋跃绒,等.西洋参茎叶总皂甙对四氧嘧啶性高血糖大鼠血脂代谢的影响[J].中西医结合心脑血管病杂志,2004,2(11):647-648.
[115]李吉平,杨世杰,刘芬.西洋参茎叶皂苷对高脂大鼠血小板聚集率及SOD活性的作用[J].白求恩医科大学学报,1996,22(4):342-344.
[116]周明学,徐浩,史大卓,等.西洋参茎叶总皂苷对载脂蛋白E基因敲除小鼠血脂及脂质代谢相关基因周脂素和CD36表达的影响[J].中国动脉硬化杂志,2007, 15(12):881-884.
[117]杨春隆,杨贵贞.西洋参茎叶总皂甙在小鼠体内外的免疫效应[J] .中国免疫学杂志,1992,8(3):188-189.
[118]吕宗智,王德凯,于晓风,等.西洋参茎叶总皂甙对免疫功能的影响[J].黑龙江中医药,1992,(5):46-48.
[119]许力军,段秀梅,钱东华,等.西洋参茎叶皂甙对CPHD患者细胞免疫功能的影响[J].中国药理学通报,2004,20(8):901-903.
[120]马文彬,马兴元,徐景达.人参与西洋参茎叶皂甙对小鼠肉瘤180细胞影响的研究[J].全国首届人参学术研讨会论文集,中国特产学会,1990:165.
[121]梁伟,孟凡娟,孙铁民,等.西洋参茎叶皂甙与新城疫病毒治疗恶性肿瘤临床应用[J].辽宁中医杂志,2005,32(8):786-787.
[122]张东吉.西洋参茎叶总皂甙对骨髓受抑模型鼠造血相关因子的调节[J].白求恩医科大学学报[J].1992,18(5):412-414.
[123]吕艳,祝彼得,冯雪梅,等.人参总皂甙和西洋参茎叶总皂甙对贫血小鼠造血影响的比较[J].成都中医药大学学报,2005,28(2):33-35,42.
[124]张颖,陆曙,刘育英,等.西洋参茎叶总皂苷对冠心病血糖异常患者胰岛素敏感性的影响[J].中国中西医结合杂志,2007,27(12):1066-1069
[125]殷惠军,张颖,杨领海,等.西洋参茎叶皂苷对胰岛素抵抗脂肪细胞葡萄糖转运、GLUT-4转位和CAP基因表达的影响[J].中国药理学通报,2007,3(10):1332- 1337.
[126]赵玉珍,刘蕾,陈立平,谭宏,王淑湘.西洋参茎叶皂甙对大鼠实验性肝损伤的影响[J].中成药2000,22(3):219-220.
[127]刘佳艳.西洋参地上部分化学成份的药理药效学研究概况[J].江苏临床医学杂志,2001,5(5):465-467.
[128]纪凤兰,徐惠波,李延忠,等.西洋参茎叶皂甙药理研究概况[J].特产研究,2000,(1):55-57.
[129]舒思洁.西洋参及其活性成份的药理学研究进展[J].时珍国医国药,2006,17 (12):2603-2604.
[130]Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989, 20(1):84-91.
[131]PontenU,Ratcheson RA,Salford LG.Optimal freezing conditions for cerebral metabolites in rats[J].Neurochem,1973,21:1127-1138.
[132]王军.大鼠脑缺血模型研究进展[J].中医研究,2002,15(5):60-62.
[133]么冬爱,张晓琴.雌激素对脑缺血的保护作用[J].中华神经科学杂志,2000,33 (4):247-249.
[134]李艳.17-β雌二醇对缺氧缺血大脑的保护作用及机制[J].国外医学.神经病学神经外科学分册,2002,29(2):115-119.
[135]Wang LJC,Futrell N,Wang DJ,et al.A Repto ducible model of middle cerebral infrarcts compatible with long-term survival in aged rats[J].stroke,1995,26(11): 2087-2090.
[136]张春银,李作,孝谭华,李晓红,刘科.尼莫地平对脑出血后缺血性脑损害保护作用的研究[J].中华老年心脑血管病杂志,2006,8(5):322-324.
[137]赵卫国,张天锡,姜智南.尼莫地平、西比灵对兔局灶脑缺血的保护作用[J].上海医学.1992,15(7):402.
[138]王凤岩,谭剑斌,杨颖,李欣,陈瑞仪.尼莫地平对皮质神经元缺糖缺氧性损伤的保护作用[J].中国卫生检验杂志,2008,18(8):1503-1504.
[139]魏汝云,王淑贞迟兆富,徐婧婧.尼莫地平对急性脑梗死患者血清基质金属蛋白酶-9及外周白细胞计数的影响[J].中国老年学杂志,2008,28(6):589-591.
[140]黄德斌,董志.尼莫地平对缺血性脑损伤大鼠神经细胞黏附分子表达的影响[J].中国药理学通报,2008,24(5):640-643.
[141]李啬夫,许宏伟,张乐,杜小平,丁玲.尼莫地平对脑出血患者脑血流动力学及血浆MMP-9的影响[J].医学临床研究,2007,24(6):937-939.
[142]沈君,李靖,赵娅琳.尼莫地平对脑缺血再灌注小鼠保护机制的研究[J].微循环学杂志,2005,15(1):24-25.
[143]张立群,陈洁丽,程焱,梁浩.尼莫地平对局灶性脑缺血鼠脑血影蛋白的影响[J].中风与神经疾病杂志,2001,18(5):300-301.
[144]杨玉亭,许爱琴,李光华.尼莫地平对大鼠急性脑缺血再灌注损伤的保护机制[J].齐齐哈尔医学院学报,2006,27(2):139-140.
[145]何宗泽,黄光富.尼莫地平治疗蛛网膜下腔出血后脑血管痉挛研究进展[J].实用医院临床杂志,2010,7(2):139-141.
[146]濮海平,刘华,侯琳,于晓燕.尼莫地平对缺氧缺血性脑损伤后细胞凋亡基因的影响[J].实用医药杂志,2007,24(11):1352-1354.
[147]沈思钰,蔡定芳,刘静,等.局灶性脑缺血神经行为及相关性分析[J].中国行为医学科学,2002,11:44-45.
[148]Longa EZ, Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke, 1989,20(1):84-91.
[149]Ward NS.Mechanisms underlying recovery of motor function affer stroke[J]. Postgrad Med J ,2005,81:510-514.
[150]Du C,Hu R,Csernansky CA,et al.Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis[J]. J Cereb Blood Flow Metab,1996,16(2): 195-201.
[151]Hill IE,MacManus JP,Rasquinha I,et al.DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat [J].Brain Res,1995,676(2):398-403.
[152]Wolf CM,Eastman A.The temporal relationship between protein- phosphatase,mitochondrial cytochrome C release and Caspase activation in apoptosis[J].EXP cell Res,1999,247(2):501-503.
[153]Petruska JC,Mendell LM.The many functions of nerve growth factor:multiple actions on nociceptors[J].Neurosci Lett,2004,361:168-171.
[154]Rabacchi SA,Ensini M,Bonfanti L,et al.Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat[J]. Neuroscience, 1994,63:969-973.
[155]Nagy Z,Simon L,Bori Z.Regulatory mechanisms in focal cerebral ischemia. New possibilities in neuroprotective therapy[J].Ideggyogy Sz,2002,55:73-85.
[156]Lindvall O,Ernfors P,Bengzon J,et al.Differential regulation of mRNAs for nerve growth factor,brain-derived neurotrophic factor and neurotrophin-3 in the adult rat brain following cerebral ischemia and hypoglycemic coma[J].Proc Nati Acad Sci USA,1992,89(2):648-652.
[157]LeeTH,Kato H,Chen ST,et al.ExPression of nerve growth factor and trkA after transient focal cerebral ischemia in rats[J].Stroke,1998,298:1687-1696.
[158]Myoken Y,Kan M,Sato GH,et al.Bifunctional effects of transforming growth factor-beta binding sites[J].Exp Cell Res,1990,191(2):299.
[159]Kyupinski J,Kumar P,Kumar S,et al.Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans[J].Stroke,1996, 27(5): 852-857.
[160]A ta KA,Lennmyr F,Funa K,et al.Expression of transforming growth factor-β1, 2,3 isoforms and typeⅠandⅡreceptors in acute focal cerebral ischemia:n immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery[J].Acta Neuro pathol (Berl), 1999, 97: 447-455.
[2]倪青,于丽红,高演.急性缺血性中风中医药研究[J].中西医结合心脑血管病杂志, 2008,6(2):127-128.
[3]于晓东.《内经》对中风病因的认识[J].时珍国医国药,2008,19(1):213-214.
[4]窦志芳,郭蕾,张俊龙,张鑫.唐宋以前中风病证治规律研究[J].中西医结合心脑血管病杂志,2006,4(4):325-326.
[5]张仲景.金匮要略方论[M].北京:人民卫生出版社,1963:14.
[6]王永炎.中医内科学[M].上海:上海科学技术出版社,1997:124.
[7]滕晶.中风病病因病机理论探析[J].中华中医药学刊,2007,25 (5):962-963.
[8]田德禄.中医内科学[M].北京:人民卫生出版社,2004:270-271.
[9]李澎涛,王永炎,黄启福.“毒损脑络”病机假说的形成及其理论与实践意义[J].北京中医药大学学报,2001,24(1):1.
[10]高颖.中风病的病因病机与辨证论治[J].中国临床医生,2001,29 (3):9-11.
[11]粟秀初.现代脑血管病学[M].北京:人民军医出版社,2003:82.
[12]刘柯,李建生.益气化瘀法对缺血性脑卒中保护作用的实验研究进展[J].中国医药学报,2004,1(19):60-64.
[13]苏志达,李瑜,李宏建.卒中治疗药物临床前的实验研究[J].国外医学脑血管疾病分册,2000,8(5):290-293.
[14]徐俊,王立.脑缺血时一氧化氮在谷氨酸兴奋毒性中的作用[J].国外医学脑血管疾病分册,1998,6(5):259-263.
[15]Hirose K,Chan PH.Blockade of glutamate excitotoxicityand its clinical applications[J].Neurochem Res,1993,18:469-483.
[16]Kristian T,Siesj BJ.Calcium-related damage in ischemia[J].Life Sci,1996,59 (516):357.
[17]陈敏,李长清,胡长林,等.钙与脑缺血/再灌注后神经细胞凋亡[J].脑与神经疾病杂志,2003,11(4):253-255.
[18]王树礼,黄晓磊,庄姗姗,杜书静.钙超载、钙结合蛋白-D28k与脑缺血关系的研究进展[J].滨州医学院学报,2009,32(1):63-66.
[19]周爽,黄建华.电针对脑缺血再灌注损伤大鼠炎症反应的影响[J].江苏中医药2005,(26)7:49-51.
[20]刘宏,吴平生.全脑缺血再灌注后发生迟发性神经元死亡的机制[J].国外医学·生理、病理科学与临床分册,1999,19(5):379-382.
[21]Reiter RJ. Oxidative damage in the central nervous system:Protection by melatonin[J].ProgNeurobio,1998,56:359-384.
[22]吴伟,史继新.脑缺血再灌注损伤后神经元损伤机制及治疗研究进展[J].中国微循环.2003,7(6):391-394.
[23]刘煜敏,徐仁伵,黄怀钧等.兴奋性氨基酸、氧自由基与缺氧再灌注脑损伤关系的实验观察[J].卒中与神经疾病.2000,7(2):98-100.
[24]张玲,余绍祖,吴国祥.大鼠脑缺血再灌注TNF-α、IL-β及细胞间粘附分子-1 mRNA的表达[J].卒中与神经疾病.2001,8(2):77-79.
[25]Shigeno T,Yamask i Y, Kato G, et al. Reduction of delayed neuronal death by inhibition protein synthesis[J]. N euro scilett,1990,120:1171-1184.
[26]Huang J,Upadhyay UM,Tamargo RJ.Inflammation in stroke and focal cerebral ischemia [J].Surg Neurol,2006,66(3):232-245.
[27]Wang Q,Tang XN,Yenari MA. The inflammatory response in stroke[J]. Neuroimmunol,2007,184(1-2):53-68
[28]方舒东,朱也森.脑缺血再灌注损伤的病理生理研究进展[J].医学综述,2006,12(18):1114-1116.
[29]Du C,Hu R,Csernansky CA,et al.Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis[J]. J Cereb Blood Flow Metab,1996, 16(2): 195-201.
[30]Hill IE,MacManus JP,Rasquinha I,et al.DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat[J]. Brain Res,1995,676(2):398-403.
[31]Wolf CM, Eastman A.The temporal relationship between protein-phosphatase,mitochondrial cytochrome C release and Caspase activation in apoptosis[J].EXP cell Res,1999,247(2):501-503.
[32]Mc Conkey DJ, Orrenius ST.The role of calcium in the regulation of apoptosis[J].Leukoc Biol,1996,59(6):725.
[33]Dodel RC,Da Y,Bales KR,et al.Caspase-3-like proteases and 6-hydrocy -Dopamine induced neuronal cell death[J].Brain Res Mol Brain Res,1999, 64(l):141.
[34]Dietrich WD,et al.Effect of the serotonin antagonist Ketomserin on the Modynamic infarction[J].Cereb Blood Flow Metab,1989,9:812-820.
[35]徐涛,曲方,周中和,宋福林.阿司匹林对脑缺血-再灌注损伤大鼠神经保护作用的机制[J].中国脑血管病杂志,2006,3(6):267-272.
[36]谭言敏.阿司匹林预防缺血性脑卒中[J].国外医学--脑血管疾病分册,1995, 3(3):131.
[37]Hoener MC,Hewirr E,Connner HM,et al.Nerve growth factor(NGF)content in adult rat brain tissues is several-fold higher than generally reported and id largely associated with sedimentable fractions[J].Brain Res,1996,728(1): 47-56.
[38]Yuen EC,Mobley WC.Therapeutic potential of neurotrophic factors for neurological disorders[J]. Ann Neurol,1996,40(3):346-354.
[39]Holtzman DM,Sheldom RA,Jaffe W,et al.Nerve growth factor proctects the neonatal brain against ischemic injury[J].Ann Neurol,1996,39(1):114-122.
[40]Arevalo MA,Rodríguez-Tébar A.Activation of casein kinase II and inh-ibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTRNTR inhibit glycogen syn-thase kinase-3βand stimulate axonal growth[J].Mol Biol Cell,2006,17(8):3369-3377.
[41]Colquhoun A,Lawrance GM,Shamovsky IL,et al.Differential activity of the nerve growth factor (NGF) antagonist PD90780 suggests altered NGF-p75NTRNTR interactions in the presence of TrkA[J].J Pharma-col Exp Ther,2004,310(2):505-511.
[42]Takeda A,Onodera H,Sugimoto A,et al.Coordinated expression of messenger RNAs for nerve growth factor,brain-derived neurotrophic factor and neurotrophin– 3 in the rat hippocampus following transient forebrain ischemia [J].Neuroscience, 1993,55(1):23-31.
[43]Hsu CY,An G,Liu JS,et al.Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat[J].Stroke,1993,24(12): 178-181.
[44]Aloe L,Lannitelli A.Neurotrophic factors and brain damage in hypoxic-ischemic encephalopathy:a role of nerve growth factor[J].Ann Ist Super Sanita,2001,37(4): 573-580.
[45]Lindvall O,Kokaia Z,Bengzon J,et al. Neurotrophins and brain insults[J].Trend Neurosci,1994,17(11):490-496.
[46]Hohn A,Leibrock J,et al.Demonstration of the retrograde transport of nerve growth factor(NGF) receptor in the peripheral and central nervous system[J]. Nature,1991,344:339.
[47]Frin D M,Short M P,Rosenberg W S,et al.Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum [J].Neurosrug,1993,78(2):267-273.
[48]Cheng B,Mattson MP.NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults[J]. Brain Res,1994,640(1):56-67.
[49]Guegan C,Ceballos Picot I,Chebalier E,et al.Reduction of ischemic damage in NGF-transgenic mice:correlation with enhancement of antiosidant enzyme activeties [J].Neurobiol Dis,1999,6(3):180-189.
[50]Cheng B,McMahon D,Mattson MP.Modulation of calcium current,intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons[J].Res,1993,607(1-2):275-285.
[51]Zhai S,Yssr M,Doyle S M,et al.Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating bcl-2 levels[J].Exp Cell Res,1996, 224(2):335-343.
[52]毕方方.NGF对大鼠局灶性脑缺血后血管再生的作用及其机制[D]湖南:中南大学,2007: 3-25.
[53]LukYO,Chen WY,Wang WJ,et al.Treatment of focal cerebral ischemia with liposomal nerve growth factor[J].DrugDeliv,2004,11(5):319-324.
[54]Ding Y,LI J,Luan X,et al.Exercise pre-conditioning reduces brain damage inischemic rats that may be associated with regional angiogenesis and cellular overexpression of neurotrophin[J].Neuroscience,2004,124(3):583-591.
[55]Andsberg G,Kokaia Z,Klein RL,et al.Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats[J].NeurobiolDis, 2002,9(2):187-204.
[56]Andsberg G,Kokaia Z,Bjorklund A,et al.Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells[J].Eur J Neurosci,1998,10(6):2026-2036.
[57]Massagué,J.TGF signal transduction[J].Annu.Rev.Biochem,1998,67:753-791.
[58]Brand,Thomas,Schneider,et al.Transforming Growth Factor-beta signal transduction[J].American Heart Association,1996,76(2):173-179.
[59]Massagué,J.The transforming growth factor-beta family[J].Annu Rev Ce11 Biol,1990,6:597-641.
[60]Sporn MB,Roberts AB,Roche NS,et al.Transforming growth factor-beta; biological function and chemical structure[J].Science,1986,233(4763):532-534.
[61]Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose6-phosphate insulin -like growth factor typeⅡreceptor[J].Proc Nat l Acad Sci USA,1991,88(2): 580-584.
[62]刘士民,郭玉璞.大鼠局灶脑缺血/再灌注模型TGF-βl的表达[J].基础医学与临床,2000,20(l):70-73.
[63]Massague J. Receptors for the TGF-beta family[J].Cell,1992,69(7):1067.
[64]Ebner R,Chen RH,Shum L,et al.Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the typeⅡreceptor[J].Science,1993,260(5112): 1344.5
[65]Lehrmann E,Kiefer R,Finsen B,et al.Cytokines in cerebral ischemia: expression of transforming growth factor beta l(TGF beta l)mRNA in the post ischemic adult rat hippocampus[J].Esp Neurol,1995,131(l):114-123.
[66]Wang X,Yue TL,White RF,et al.Transforming growth factor beta 1 exhibitsdelayed gene expression following focal cerebral ischemia[J].Brain Res Bull,1995,36(6):607-609.
[67]Knuckey NW,Finch P,Palm DE,et al.Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia[J].Brain Res Mol Brain Res,1996,40(l): l-14.
[68]艾婷,孙晓勉.转化生长因子β1与缺氧缺血性脑损伤关系的研究进展[J].新生儿科杂志,2005,20(3):140-143.
[69]Henrich-Noack P,Prehn JH,Krieglstein J.TGF-beta l protects hippocampal neurons against degeneration caused by transient global ischemia. Dose response relationship and potential neuroprotective mechanisms[J].Stroke,1996, 27(9):1609-1614.
[70]Sometani A,Kataoka H,Nitta A,et al.Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor,TrkB,in neurons cultured from rat ccrebral cortex[J].J Neurosci Res,2001,66(3):369-376.
[71]DhandaPani KM,Brann DW.Transforming growth factor-beta:a neuroprotective factor in cerebral ischemia[J].Cell Biochem Biophys,2003,39(l):13-22.
[72]胡治平.转化生长因子β与缺血性脑损伤(综述)[J].国外医学神经病学神经外科学分册,2000,27(2):9799.
[73]Klaus Unsieker,Jens Strelau.Functions of transforming growth factor-βisoforms in the nervous system Cues based on localization and experimental in vitro and in vivoevidence[J].EJ.Bioehem,2000,267:6972-6975.
[74]Shih S,Ju M,Liu N,et al.Transforming growth factor induction of vascular endothelial growth factor receptor l:Mechanism of pericyte-inducted vascular survival in vivo[J]. Proc Natl Acad Sci USA,2003,100(26):15859-15864.
[75]John GR,Lee SC,Brosnan CF,et al.Cytokines: powerful regulators of glial cell activation[J].Neuroscientist,2003,9(1):10-22.
[76]KruPinski J,Kumar P,Kumar S,et al.Increased expression of TGF-beta 1 in brain tissue after ischemic storke in humans[J].Stroke,1996,27(5):852-857.
[77]Unsicker K,Krieglstein K.TGF-betas and their roles in the regulation ofneuronsurvival[J].Adv Exp Med Biol,2002,513:353-374.
[78]Brionne TC,Tesseur I,Masliah E,et al.Loss of TGF-βl leads to increased neuronal cell death and microgliosis in mouse brain[J].Neuron,2003,40: 1133-1145.
[79]Roussel S,Mackenzie ET,Vivien D,et al.A transforming growth factor beta antagonist unrnasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury[J].J Cereb Blood Flow Metab,1999,19(12): 1345-1353.
[80]刘铁成.中国西洋参[M].北京:人民卫生出版社,1995
[81]曹立军,许永华,于淑莲,等.我国西洋参产业发展现状概述[J].人参研究,2002, 14(1):36-38.
[82]都晓伟,刘艳艳,李滨.从化学和药理学的角度探讨人参、西洋参和三七的传统应用[J].中医药学报,2005,33(4):66-69.
[83]鲍建材,刘刚,郑友兰.西洋参中皂苷类成份的研究[J].人参研究,2004,(1):7-9.
[84]魏春雁,牟金明.西洋参化学成分研究现状[J].特产研究.1997,(4):39-41.
[85]王蕾,王英平,许世良,等.西洋参化学成份及药理活性研究进展[J].特产研究,2007,(3):73-77.
[86]任贵兴,王铁生,吕明山.西洋参根茎叶总皂苷、氨基酸及无机元素含量的研究[J].特产科学实验,1987,(4):1-3.
[87]陆丰,睢大员,于晓风,等.西洋参叶20S-原人参二醇组皂苷对急性心肌梗死大鼠交感神经递质及肾素-血管紧张素系统的影响[J].中草药,2001,32(7):619-621.
[88]武淑芳,睢大员,于晓风,等.西洋参20S-原人参二醇组皂苷抗实验性心肌缺血作用及其机制[J].中国药学杂志,2002,37(2):100-103.
[89]刘尚裕,睢大员,于小风,等.西洋参叶20S-原人参二醇组皂苷对急性心肌梗死犬血流动力学和氧代谢的影响[J].中国药学杂志,2001,36(1):25-29.
[90]睢大员,于晓风,曲绍春,等.西洋参叶20S-原人参二醇组皂苷对犬急性心肌梗死的保护作用[J].中国中药杂志,2001,26(6):416-419.
[91]边城,吕忠智.西洋参茎叶皂苷对实验性心肌坏死的保护作用[J].中国药理学通报,1994,10(6):442-444.
[92]王承龙,史大卓,殷惠军,陈可冀.西洋参茎叶总皂苷对急性心肌梗死大鼠心肌VEGF、bFGF表达及血管新生的影响[J].中国中西医结合杂志,2007,27( 4):331- 334.
[93]王尚农,马欣,赵东科.西洋参茎叶皂苷对豚鼠心室乳头状肌动作电位和收缩力的影响[J].西安医科大学学报,1994,15(2):122-124.
[94]杨世杰,李红,张文杰,等.西洋参茎叶皂苷对培养犬鼠心肌细胞钙通道阻断作用的初步观察[J].中国药学杂志,1994,29 (9):525-527.
[95]马欣,赵松珍,王尚农.西洋参茎叶皂苷对家兔窦房结电活动和豚鼠心肌收缩性的影响[J].西安医科大学学报,1998,19(1):47-48.
[96]关利新,衣欣,杨世杰,等.西洋参茎叶皂苷对大鼠心肌细胞Ca2+内流的影响[J].中药药理与临床,2004,20(6):8-9.
[97]杨世杰,陈立,赵华,等.西洋参茎叶皂苷对豚鼠左心房收缩力及右心房起搏点的作用[J].白求恩医科大学学报,1994,20(2):122-124.
[98]李智,于晓风,曲绍春,徐华丽,睢大员.西洋参叶20S-原人参三醇组皂苷对大鼠心肌缺血再灌注损伤的保护作用[J].2009,35(1):51-54.
[99]马琼英,周文祥,高鸣,等.西洋参茎叶皂苷对中分子物质损伤心肌的保护作用的实验研究[J].中国中西医结合肾病杂志,2000,1 (2):79-81.
[100]王承龙,缪宇,殷惠军,等.西洋参茎叶总皂苷对急性心肌梗死大鼠心肌能量代谢的影响[J].中华老年心脑血管病杂志,2005,7 (5):341-343.
[101]范宝晶,裴非,赵学忠.西洋参茎叶总皂苷对心肌肥厚大鼠血管内皮功能的影响[J].中国老年学杂志,2009,29(7):811-812.
[102]吕忠智,张清兰,于晓凤,周鸣.西洋参茎叶皂甙对实验性心肌梗塞的保护作用.白求恩医科大学学报,1990,16:229-23l.
[103]李松云,郭力达,王健春,章建邦.西洋参茎叶皂甙对失血性休克及对心脏的保护作用.中华医学杂志,1990,70:411-412.
[104]郭力达,李松云,王健春.西洋参茎叶总皂甙对失血性休克鼠组织过氧化脂质含量的影响.白求忍医科大学学报,1990,16:556-558.
[105]马春力,吕忠智,姜永冲.西洋参茎叶皂甙在阿霉素诱导大鼠心肌损伤中的抗氧化作用.中国药理学与毒理学杂志,1993,7:267-269.
[106]杨世杰,曲极冰,钟国,张文杰.西洋参茎叶皂甙对大鼠培养心肌细胞氧化损伤的保护作用.中国中药杂志,1992,17:555-557.
[107]李吉平,吕忠智,吕怡芳.西洋参茎叶皂甙对高脂血症大鼠脂蛋白-胆固醇代谢的影响及其抗氧化作用.中国药学杂志,1993,28:355-357.
[108]马春力,崔凤起,郭忠兴,王力.西洋参茎叶皂甙对老年大鼠血清和组织中超氧化物歧化酶的作用.老年学杂志,1993,13:304-305.
[109]马春力,李福全,赵玉珍.西洋参茎叶皂甙对急性乙醇中毒大鼠肝损害的影响.佳末斯医学院学报,1992,(6):18-19.
[110]刘巍.西洋参茎叶20s-原人参二醇组皂苷对大鼠实验性脑缺血的影响[D].长春:吉林大学药学院,2007:5-35.
[111]关利新,翟凤国,聂影,包海花,苏云明.西洋参茎叶皂苷对脑缺血大鼠细胞凋亡及caspase-3表达的影响[J].中药药理与临床,2008,24(1):30-32.
[112]包海花,袁晓环,韩雪山,高晓红,关利新,初彦辉.西洋参皂苷对H2O2致PC12细胞损伤的保护作用[J].中国生化药物杂志,2009,30(5):302-305.
[113]吕忠智,睢大篑.西洋参茎叶皂甙的心血管药理研究进展[J].中国药理学通报, 1996,12(5):395-396.
[114]殷惠军,张颖,蒋跃绒,等.西洋参茎叶总皂甙对四氧嘧啶性高血糖大鼠血脂代谢的影响[J].中西医结合心脑血管病杂志,2004,2(11):647-648.
[115]李吉平,杨世杰,刘芬.西洋参茎叶皂苷对高脂大鼠血小板聚集率及SOD活性的作用[J].白求恩医科大学学报,1996,22(4):342-344.
[116]周明学,徐浩,史大卓,等.西洋参茎叶总皂苷对载脂蛋白E基因敲除小鼠血脂及脂质代谢相关基因周脂素和CD36表达的影响[J].中国动脉硬化杂志,2007, 15(12):881-884.
[117]杨春隆,杨贵贞.西洋参茎叶总皂甙在小鼠体内外的免疫效应[J] .中国免疫学杂志,1992,8(3):188-189.
[118]吕宗智,王德凯,于晓风,等.西洋参茎叶总皂甙对免疫功能的影响[J].黑龙江中医药,1992,(5):46-48.
[119]许力军,段秀梅,钱东华,等.西洋参茎叶皂甙对CPHD患者细胞免疫功能的影响[J].中国药理学通报,2004,20(8):901-903.
[120]马文彬,马兴元,徐景达.人参与西洋参茎叶皂甙对小鼠肉瘤180细胞影响的研究[J].全国首届人参学术研讨会论文集,中国特产学会,1990:165.
[121]梁伟,孟凡娟,孙铁民,等.西洋参茎叶皂甙与新城疫病毒治疗恶性肿瘤临床应用[J].辽宁中医杂志,2005,32(8):786-787.
[122]张东吉.西洋参茎叶总皂甙对骨髓受抑模型鼠造血相关因子的调节[J].白求恩医科大学学报[J].1992,18(5):412-414.
[123]吕艳,祝彼得,冯雪梅,等.人参总皂甙和西洋参茎叶总皂甙对贫血小鼠造血影响的比较[J].成都中医药大学学报,2005,28(2):33-35,42.
[124]张颖,陆曙,刘育英,等.西洋参茎叶总皂苷对冠心病血糖异常患者胰岛素敏感性的影响[J].中国中西医结合杂志,2007,27(12):1066-1069
[125]殷惠军,张颖,杨领海,等.西洋参茎叶皂苷对胰岛素抵抗脂肪细胞葡萄糖转运、GLUT-4转位和CAP基因表达的影响[J].中国药理学通报,2007,3(10):1332- 1337.
[126]赵玉珍,刘蕾,陈立平,谭宏,王淑湘.西洋参茎叶皂甙对大鼠实验性肝损伤的影响[J].中成药2000,22(3):219-220.
[127]刘佳艳.西洋参地上部分化学成份的药理药效学研究概况[J].江苏临床医学杂志,2001,5(5):465-467.
[128]纪凤兰,徐惠波,李延忠,等.西洋参茎叶皂甙药理研究概况[J].特产研究,2000,(1):55-57.
[129]舒思洁.西洋参及其活性成份的药理学研究进展[J].时珍国医国药,2006,17 (12):2603-2604.
[130]Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989, 20(1):84-91.
[131]PontenU,Ratcheson RA,Salford LG.Optimal freezing conditions for cerebral metabolites in rats[J].Neurochem,1973,21:1127-1138.
[132]王军.大鼠脑缺血模型研究进展[J].中医研究,2002,15(5):60-62.
[133]么冬爱,张晓琴.雌激素对脑缺血的保护作用[J].中华神经科学杂志,2000,33 (4):247-249.
[134]李艳.17-β雌二醇对缺氧缺血大脑的保护作用及机制[J].国外医学.神经病学神经外科学分册,2002,29(2):115-119.
[135]Wang LJC,Futrell N,Wang DJ,et al.A Repto ducible model of middle cerebral infrarcts compatible with long-term survival in aged rats[J].stroke,1995,26(11): 2087-2090.
[136]张春银,李作,孝谭华,李晓红,刘科.尼莫地平对脑出血后缺血性脑损害保护作用的研究[J].中华老年心脑血管病杂志,2006,8(5):322-324.
[137]赵卫国,张天锡,姜智南.尼莫地平、西比灵对兔局灶脑缺血的保护作用[J].上海医学.1992,15(7):402.
[138]王凤岩,谭剑斌,杨颖,李欣,陈瑞仪.尼莫地平对皮质神经元缺糖缺氧性损伤的保护作用[J].中国卫生检验杂志,2008,18(8):1503-1504.
[139]魏汝云,王淑贞迟兆富,徐婧婧.尼莫地平对急性脑梗死患者血清基质金属蛋白酶-9及外周白细胞计数的影响[J].中国老年学杂志,2008,28(6):589-591.
[140]黄德斌,董志.尼莫地平对缺血性脑损伤大鼠神经细胞黏附分子表达的影响[J].中国药理学通报,2008,24(5):640-643.
[141]李啬夫,许宏伟,张乐,杜小平,丁玲.尼莫地平对脑出血患者脑血流动力学及血浆MMP-9的影响[J].医学临床研究,2007,24(6):937-939.
[142]沈君,李靖,赵娅琳.尼莫地平对脑缺血再灌注小鼠保护机制的研究[J].微循环学杂志,2005,15(1):24-25.
[143]张立群,陈洁丽,程焱,梁浩.尼莫地平对局灶性脑缺血鼠脑血影蛋白的影响[J].中风与神经疾病杂志,2001,18(5):300-301.
[144]杨玉亭,许爱琴,李光华.尼莫地平对大鼠急性脑缺血再灌注损伤的保护机制[J].齐齐哈尔医学院学报,2006,27(2):139-140.
[145]何宗泽,黄光富.尼莫地平治疗蛛网膜下腔出血后脑血管痉挛研究进展[J].实用医院临床杂志,2010,7(2):139-141.
[146]濮海平,刘华,侯琳,于晓燕.尼莫地平对缺氧缺血性脑损伤后细胞凋亡基因的影响[J].实用医药杂志,2007,24(11):1352-1354.
[147]沈思钰,蔡定芳,刘静,等.局灶性脑缺血神经行为及相关性分析[J].中国行为医学科学,2002,11:44-45.
[148]Longa EZ, Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke, 1989,20(1):84-91.
[149]Ward NS.Mechanisms underlying recovery of motor function affer stroke[J]. Postgrad Med J ,2005,81:510-514.
[150]Du C,Hu R,Csernansky CA,et al.Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis[J]. J Cereb Blood Flow Metab,1996,16(2): 195-201.
[151]Hill IE,MacManus JP,Rasquinha I,et al.DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat [J].Brain Res,1995,676(2):398-403.
[152]Wolf CM,Eastman A.The temporal relationship between protein- phosphatase,mitochondrial cytochrome C release and Caspase activation in apoptosis[J].EXP cell Res,1999,247(2):501-503.
[153]Petruska JC,Mendell LM.The many functions of nerve growth factor:multiple actions on nociceptors[J].Neurosci Lett,2004,361:168-171.
[154]Rabacchi SA,Ensini M,Bonfanti L,et al.Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat[J]. Neuroscience, 1994,63:969-973.
[155]Nagy Z,Simon L,Bori Z.Regulatory mechanisms in focal cerebral ischemia. New possibilities in neuroprotective therapy[J].Ideggyogy Sz,2002,55:73-85.
[156]Lindvall O,Ernfors P,Bengzon J,et al.Differential regulation of mRNAs for nerve growth factor,brain-derived neurotrophic factor and neurotrophin-3 in the adult rat brain following cerebral ischemia and hypoglycemic coma[J].Proc Nati Acad Sci USA,1992,89(2):648-652.
[157]LeeTH,Kato H,Chen ST,et al.ExPression of nerve growth factor and trkA after transient focal cerebral ischemia in rats[J].Stroke,1998,298:1687-1696.
[158]Myoken Y,Kan M,Sato GH,et al.Bifunctional effects of transforming growth factor-beta binding sites[J].Exp Cell Res,1990,191(2):299.
[159]Kyupinski J,Kumar P,Kumar S,et al.Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans[J].Stroke,1996, 27(5): 852-857.
[160]A ta KA,Lennmyr F,Funa K,et al.Expression of transforming growth factor-β1, 2,3 isoforms and typeⅠandⅡreceptors in acute focal cerebral ischemia:n immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery[J].Acta Neuro pathol (Berl), 1999, 97: 447-455.